Details of the impact
Healthcare suffers because of preventable errors. IT is a solution but also a current problem. The impact of our research can be described in the following ways:
Policy debate stimulated and informed by research. We conceived of and ran “Tully Meetings” (named after Prof Colin Tully, one of the founders of the NHS23 group) to bring top computer scientists and clinicians.
Potential losses mitigated by improved risk assessment by health service. Collaborating with the NHS we showed in the largest ever study poor design of infusion pumps induces wastage of ~£1,000/pump/year.
Public discourse stimulated and informed. We have given 120+ presentations (in REF period) at medical conferences, industrial seminars and workshops at international conferences such as ACM CHI (2010; 2011; 2013), ACM EICS (2011; 2012; 2013), BCS HCI (every year), as well as presentations to CTOs of many organizations and hospital trusts.
Improved quality, efficiency & productivity of professional service. Drug doses rely on complex calculations. We developed calculators that eliminate some sources of error completely. A prototype was exhibited at a Royal Society Summer Science exhibition in 2005 and in TECHFEST, in Mumbai, India, etc.
Defined best practice for professional bodies and learned societies. The Royal College of Physicians, the Royal College of Anaesthetists, the Royal College of Physicians Edinburgh, the Royal College of Pharmacists, Guild of Healthcare Pharmacists, Scottish Intensive Care Society, Central Sterilising Committee, Scottish Clinical Skills Network, etc, have had invited lectures from us. We have undertaken confidential assessments of medical devices for the NHS in respect of criminal and professional investigations.
Significance Our impact is increasing, but even if applied unchanged today we could prevent ~7,000 UK deaths/year, with additional social benefits in finance and wellbeing, and additional impact for the “second victims,” the clinicians who have to operate this equipment.